- Management and control
- Key products, services, and business processes
- Important markets and competitive position
- Legal and economic factors
- Capital, shareholders, articles of association
Important markets and competitive position
Fresenius operates in more than 70 countries through its subsidiaries. The main markets are Europe and North America. Fresenius generates 44% of its sales in North America and 41% in Europe.
Fresenius Medical Care is the worldwide leader in dialysis. The company holds the leading position in dialysis care, with a market share of 18% in revenue terms, treats the most dialysis patients, and operates the largest number of dialysis clinics. In dialysis products, Fresenius Medical Care is also the leading supplier, with a market share of about 33%. Fresenius Kabi holds leading market positions in Europe and has strong positions in the growth markets of Asia-Pacific and Latin America. In the United States, Fresenius Kabi is the second largest supplier of generic IV drugs. Fresenius Helios is one of the top three private hospital operators in Germany. Fresenius Vamed is one of the world’s leading companies specializing in engineering and services for hospitals and other health care facilities.
Legal and economic factors